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 Abstract. The necessity and the importance on tackling this subject is due to the presence of this cancer 
forms (leukemias and malignant lymphomas) in humans and in animals, but with a greater incidence in 
companion animals (dogs, cats) and mostly in dogs. 
 Following the epidemiologic, anatomy-pathology and evolution studies, mainly stressing the 
hematological aspects and the problems relied on the cellular basis of the malignant proliferation, were observed 
that they have very many resemblances with those for humans. 
 
INTRODUCTION 
 
 Our vast experience during the last 12 years in the domain of malignant hemopathies 
in company animals (due to the School of Veterinary Oncohematology created 40 years ago 
(in 1967) by Prof. Nicolae Manolescu) was presented in a large number of scientific works 
presented in many national and international scientific meetings, let's mention the Congresses 
of Comparative Oncology. 
 This work comparatively presents the similitude existent in the morphocytologic 
manifestations of malignant hemopathies in dogs and humans. We insist on the cytological 
typology of the peripheral blood, hematopoietic marrow, lymphonodal and spleen territory. 
 
MATERIAL AND METHOD 
 
 We present the situation of malignant hemopathies in dogs between 2005 and 2007. 
111dogs were diagnosed with malignant hemopathies, 22 cases were different cases of 
leukemias and 89 cases presented different forms of malignant lymphomas. 
 The ratio of the incidence of malignant hemopathies and the total malignant 
oncopathies is 50%, being the most frequent cancer form in dogs. The malignant hemopathies 
in dog were diagnosed at any age, having a quasi-equal repartition on sex and breed of the 
diseased animals. 
 The most important matter for a positive and differential diagnosis in malignant 
hemopathies is represented by a close cooperation between clinicians and specialists in 
imaging and laboratory diagnosis. 
 Together with the anamnesis and the general clinic examinations, and also the 
biochemical and hematologic cytomorphological and histopathologic examinations were 
made imagistic, flow-cytometry examinations and tumoral markers. 
 Complex quantitative hematological examinations were made with the Coulter 
Counter, by examination of integral blood smears and also the leukocyte concentrate (LCT). 
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This examination can replace the medullar aspirate for the study of hematopoietic cells, 
especially in leucopenias and pancytopenias, determining us to practice currently these in the 
laboratory. Also the examination of the LCT has value for the positive diagnosis in cases of 
malignant lymphomas with cytemic discharge and also for the diagnosis of leukemoid 
reactions. 
 The hematologic examination was completed in some cases with the hematopoietic 
marrow examination, the biopuncture of lymphonodes in the case of external adenopathias, 
spleen anf internal lymphonodes punctures in the case of surgery interventions. 
 As work method were made smears that were analyzed after classic May-Grünwald-
Giemsa dye and also the AgNOR dye. Together with the cytomorphological examinations 
were made histopathological examinations, flow-cytometry examinations and tumoral 
markers. 
 
RESULTS AND DISCUSSIONS 
 
 Corroborating data from the above mentioned investigations, we diagnosed following 
forms of malignant hemopathies in dogs, classifying them as follows: 
 A. Leukemias: 
A.1. Acute lymphoblastic leukemia (LLA) 
A.2. Acute mieloid leukemia (LMA), that can evolve as: 
Erythroid leukemia 
Megacarioblastic leukemia 
Histio-monocyte leukemia 
Monocyte leukemia 
Promielocyte leukemia 
Mieloblastic leukemia: macromieloblastic and micromieloblastic 
A.3. Chronic mieloid leukemia (LMC) 
Chronic lymphoid leukemia (LLC) 
Chronic leukemia with hairy cells 
Plasmocytar chronic leukemia 
 
 B. Malignant lymphomas 
B.1. Hodgkin lymphoma 
B.2. Non-Hodgkin lymphoma 
T cellular 
B cellular 
histiocytic 
N.K. 
Bone mieloma 
Extra-bone plasmocytoma 
Waldenström 
 
CONCLUSIONS 
 
The malignant hemopathies in canides are the most frequent forms among the cancer 
disease manifestations in general. 
The malignant lymphomas frequency is much greater as the leukemias frequency in ratio 
of 5/1. 
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The malignant hemopathies in dog present cytomorphologic similitudes with those in 
humans. So we may conclude: 
the need to study them permanently and more profound in the domain of Comparative 
Oncology 
the malignant hemopathies in dogs will be the basis of a model of clinic "pretrial" for the 
human medicine. 
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